{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:48:08Z","timestamp":1777182488648,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jhep.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T16:35:27Z","timestamp":1471883727000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population"],"prefix":"10.1016","volume":"66","author":[{"given":"Hamish","family":"Innes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wilks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diptendu","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bramley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon J.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.08.004_b0005","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.08.004_b0010","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.08.004_b0015","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/cir076","article-title":"Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more","volume":"52","author":"Pearlman","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2016.08.004_b0020","unstructured":"\u201cPamela Anderson says: I\u2019m cured of Hep C\u201d. Accessed December 2015. http:\/\/www.thesun.co.uk\/sol\/homepage\/showbiz\/6732270\/Pamela-Anderson-cured-of-Hepatitis-C.html."},{"key":"10.1016\/j.jhep.2016.08.004_b0025","unstructured":"Your moment to cure. Viekira homepage. Accessed January 2016. https:\/\/www.viekira.com\/."},{"key":"10.1016\/j.jhep.2016.08.004_b0030","unstructured":"I am hepatitis C cured. Sovaldi homepage. Accessed January 2016. http:\/\/www.sovaldi.com\/."},{"key":"10.1016\/j.jhep.2016.08.004_b0035","unstructured":"Hepatitis C virus can be cured in 12 weeks with drug course: study. Accessed December 2015. http:\/\/www.huffingtonpost.ca\/2015\/11\/18\/hepatitis-c-cure_n_8592704.html."},{"key":"10.1016\/j.jhep.2016.08.004_b0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2008.05.044","article-title":"Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"135","author":"Maylin","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.08.004_b0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.08.004_b0050","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","article-title":"Hepatocellular carcinoma and hepatitis C in the United States","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.08.004_b0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jhep.2014.09.001","article-title":"Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment","volume":"62","author":"Aspinall","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.08.004_b0060","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.08.004_b0065","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ396","article-title":"Long term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response","volume":"61","author":"Simmons","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2016.08.004_b0070","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/biostatistics\/kxl030","article-title":"Estimating and modelling the cure fraction in population-based cancer survival analysis","volume":"8","author":"Lambert","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.jhep.2016.08.004_b0075","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/annonc\/mdu383","article-title":"Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types","volume":"25","author":"Del Maso","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2016.08.004_b0080","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.2014.12627","article-title":"Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population","volume":"312","author":"Van der Meer","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2016.08.004_b0085","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jhep.2016.01.034","article-title":"Survival of patients with HCV cirrhosis and sustaeind virologic response is similar to the general population","volume":"64","author":"Bruno","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.08.004_b0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","article-title":"The present and future disease burden of hepatitis C virus (HCV) infection with today\u2019s treatment paradigm","volume":"21","author":"Razavi","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2016.08.004_b0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.27766","article-title":"Towards a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes","volume":"62","author":"Innes","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.08.004_b0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jhep.2016.08.004_b0105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jhep.2016.08.004_b0110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet-ratio index for the stage of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.08.004_b0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/MEG.0b013e32835201a4","article-title":"Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland","volume":"24","author":"Innes","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.08.004_b0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MEG.0b013e32831101b7","article-title":"Hepatocellularcarcinoma after sustained virologic response in hepatitis C patients with cirrhosis on a pretreatment liver biopsy","volume":"21","author":"Sewell","year":"2009","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.jhep.2016.08.004_b0125","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1440-1746.1996.tb00280.x","article-title":"Case report: development of hepatocellular carcinoma in a patients with chronic hepatitis C infection after a complete and sustained response to interfetron-alpha","volume":"11","author":"Hirashima","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.08.004_b0130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2008.01006.x","article-title":"Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C","volume":"15","author":"Scherzer","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2016.08.004_b0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1665-2681(19)31814-9","article-title":"Hepatocellular carcinoma in a hepatitis C patients with sustained viral response and no fibrosis","volume":"8","author":"Tabibian","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2016.08.004_b0140","article-title":"Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: a large-scale, long-term cohort study","author":"Nagaoki","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.08.004_b0145","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.24561","article-title":"Excess liver-related morbidity of chronic hepatitis C patients who achieve a sustained viral response and are discharged from care","volume":"54","author":"Innes","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.08.004_b0150","doi-asserted-by":"crossref","first-page":"e22476","DOI":"10.1371\/journal.pone.0022476","article-title":"Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study","volume":"6","author":"Omland","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2016.08.004_b0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/CLEP.S43926","article-title":"Socioeconomic status in HCV infected patients \u2013 risk and prognosis","volume":"5","author":"Omland","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jhep.2016.08.004_b0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.28535","article-title":"Risk of hepatocellular carcinoma after sustained virological response in veterans with hepatitis C virus infection","volume":"64","author":"El-Serag","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.08.004_b0165","unstructured":"Stephan Wiktor. Hepatitis B and C public policy association meeting: EU HCV Brussels, 17th February 2016. http:\/\/www.hcvbrusselssummit.eu\/material\/summit-podcast (accessed April 2016)."}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816304287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816304287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:29:58Z","timestamp":1771964998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816304287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0168827816304287"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.08.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}